Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00526786 · ClinicalTrials.gov registry record · Phase 4

Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus

A Phase 4 study, sponsored by CSA Medical.

Terminated
Registry status
Phase 4
Development phase
78
Enrollment target

NCT00526786: Clinical Trial Phase 4 study, sponsored by CSA Medical.

NCT00526786 is a Phase 4 study that was terminated before completion, run by CSA Medical. The registered enrollment target is 78 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00526786, a Phase 4 study, was terminated before completion, sponsored by CSA Medical.

TERMINATED
Registry status
Phase 4
Development phase
78 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the safety and effectiveness of the CryoSpray Ablation System to treat esophageal low grade dysplasia (LGD) or high grade dysplasia (HGD) within Barrett's Esophagus (BE).

Interventions

  • DEVICE CryoSpray Ablation System (510(k) NO: K070893)

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2007-09
Est. Completion 2009-09
Phase Phase 4
CSA Medical

9 total trials

Why NCT00526786 stopped before completion

NCT00526786 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 1 intervention - of which CryoSpray Ablation System (510(k) NO: K070893) is the first listed.

NCT00526786 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00526786 about?

NCT00526786 is a clinical study titled "Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus". The purpose of this study is to evaluate the safety and effectiveness of the CryoSpray Ablation System to treat esophageal low grade dysplasia (LGD) or high grade dysplasia (HGD) within Barrett's Esophagus (BE).

What is the current status of trial NCT00526786?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 78 participants. The study started on 2007-09. Estimated completion is 2009-09.

What interventions are being tested in trial NCT00526786?

The interventions under investigation include: CryoSpray Ablation System (510(k) NO: K070893) (DEVICE).

Who is sponsoring clinical trial NCT00526786?

This trial is sponsored by CSA Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00526786's enrollment target sits among peer trials

78 982nd of 2000 higher than 1,012 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02397668 · 78 participants · NA

    CorMatrix Cor TRICUSPID ECM Valve Replacement Study

  • NCT03321656 · 78 participants · Phase 2

    Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

  • NCT03687814 · 78 participants · NA

    Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation

  • NCT04018872 · 78 participants · Phase 2

    Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00526786, the US trial registry maintained by the National Library of Medicine. NCT00526786 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.